Venus Concept is a global medical technology company that develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies. Co.'s products include: Venus Legacy, in which the Venus Legacy BX is a noninvasive device intended for use in dermatological and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick Skin Types I-IV; Venus Versa, in which the Venus Versa system is a multi-application device intended for use in aesthetic and cosmetic procedures; and Venus Glow, in which Venus Glow is a motorized dermabrasion device. The VERO average annual return since 2017 is shown above.
The Average Annual Return on the VERO average annual return since 2017 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether VERO average annual return since 2017 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the VERO average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|